Z Squared ZSQR
NASDAQ ZSQR
$3.97 +0.02 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Z Squared (ZSQR) Gross Margin (2025 - 2026)

Updated

Z Squared's Gross Margin was -111.52% in Q2 2026, down 171.83 percentage points from the prior quarter.

Analysis

Z Squared (ZSQR) Gross Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Z Squared's Gross Margin was -24.61% through Jun 30, 2026, down 52.79 percentage points year-over-year; for FY2025, it was 86.75%.

  • Gross Margin shows a four-year change of -13.25 percentage points (FY2021 to FY2025).
  • In earlier years, Gross Margin was 100.00% in FY2021.
  • Per Business Quant data, ZSQR's Gross Margin in the three quarters before Q2 2026 was 60.31% (Q1 2026), 94.76% (Q4 2025) and 80.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 68.19%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 74.74%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 73.54%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 78.02%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 83.60%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 72.04%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 79.76%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 72.78%
10 Z Squared 210.41 Mn 183.65 Mn -1.77 Mn -111.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -111.52%
Mar 31, 2026 60.31%
Dec 31, 2025 94.76%
Sep 30, 2025 80.98%
Mar 31, 2025 28.18%
API Access

Z Squared Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ZSQR&period=max&api_key=YOUR_API_KEY